DNAJC1 and glioblastoma: The CGGA database analysis corroborated these findings, revealing an inverse relationship between DNAJC1 expression and OS in patients with either initial or recurrent GBM (Fig. 2G, H), further supporting DNAJC1’s role as a negative prognostic indicator.